Innovation and Commercialization of Therapeutics for Metabolic Disorders
Conference - Baltimore, Maryland, United States
The skyrocketing growth rates of both obesity and type-2 diabetes are widely recognized as public health threats. With so many unmet and ever-growing needs, this market represents possibly the last remaining opportunity for new blockbuster drugs. IIR’s inaugural Innovation and Commercialization of Therapeutics for Metabolic Disorders conference is your best opportunity to gain success strategies for these technical, regulatory and market access hurdles, as delivered by the leaders in the industry. Plus, gain market-leading insights into the next breakthrough that will revolutionize this space, through an examination of the sequencing of the internal microbiome and its meaning for metabolic health and the performance of pharmaceuticals and medicinal foods.
Web: http://www.iirusa.com/metabolic/home.xml
Mariott Inner Harbor at Camden Yards
Baltimore, Maryland, United States
Monday, February 11, 2013 to Tuesday, February 12, 2013 (7:45am)
Contact: Roxana Siu (rsiu@iirusa.com)
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
